GRANULES.NS Profit & Loss
Granules India Ltd.
Profit & Loss Balance Sheet Cash Flow
Profit & Loss · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 22:31
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Revenue from Operations | ₹45.12 Bn | ₹45.06 Bn | ₹44.82 Bn | ₹53.66 Bn | RevenueFromOperations |
| Gross Revenue (incl. inter-segment) | N/A | N/A | N/A | N/A | SegmentRevenueFromOperations |
| Other Income | ₹0.14 Bn | ₹0.04 Bn | ₹0.13 Bn | ₹0.20 Bn | OtherIncome |
| Total Income | ₹45.26 Bn | ₹45.11 Bn | ₹44.95 Bn | ₹53.86 Bn | Income |
| Cost of Materials Consumed | ₹23.53 Bn | ₹22.08 Bn | ₹17.25 Bn | ₹21.00 Bn | CostOfMaterialsConsumed |
| Purchases of Stock-in-Trade | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | PurchasesOfStockInTrade |
| Changes in Inventories | ₹-0.45 Bn | ₹-1.87 Bn | ₹0.01 Bn | ₹-2.24 Bn | ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade |
| Employee Benefit Expense | ₹4.72 Bn | ₹5.98 Bn | ₹6.60 Bn | ₹8.88 Bn | EmployeeBenefitExpense |
| Finance Costs | ₹0.56 Bn | ₹1.06 Bn | ₹1.03 Bn | ₹1.14 Bn | FinanceCosts |
| Depreciation and Amortisation | ₹1.84 Bn | ₹2.07 Bn | ₹2.26 Bn | ₹2.96 Bn | DepreciationDepletionAndAmortisationExpense |
| Other Expenses | ₹8.19 Bn | ₹10.31 Bn | ₹11.51 Bn | ₹14.16 Bn | OtherExpenses |
| Total Expenses | ₹38.39 Bn | ₹39.64 Bn | ₹38.65 Bn | ₹45.91 Bn | Expenses |
| Profit Before Exceptional Items and Tax | ₹6.87 Bn | ₹5.47 Bn | ₹6.29 Bn | ₹7.95 Bn | ProfitBeforeExceptionalItemsAndTax |
| Exceptional Items | ₹0.00 Bn | ₹0.00 Bn | ₹0.31 Bn | ₹-0.10 Bn | ExceptionalItemsBeforeTax |
| Profit Before Tax | ₹6.87 Bn | ₹5.47 Bn | ₹6.60 Bn | ₹7.85 Bn | ProfitBeforeTax |
| Tax Expense | ₹1.71 Bn | ₹1.42 Bn | ₹1.59 Bn | ₹1.90 Bn | TaxExpense |
| Net Profit (incl. minority interest) | ₹5.17 Bn | ₹4.05 Bn | ₹5.02 Bn | ₹5.95 Bn | ProfitLossForPeriod |
| Net Profit (to shareholders) | ₹5.17 Bn | ₹4.26 Bn | ₹5.02 Bn | N/A | ProfitOrLossAttributableToOwnersOfParent |
| Basic EPS | ₹21.05 | ₹16.73 | ₹20.69 | ₹24.47 | BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
| Diluted EPS | ₹21.00 | ₹16.72 | ₹20.68 | ₹24.46 | DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
Every figure above is the exact value of the named XBRL element from GRANULES.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).